PR Newswire
SAN DIEGO, June 3, 2016
SAN DIEGO, June 3, 2016 /PRNewswire/ -- aTyr Pharma, Inc.
(Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address
severe rare diseases, today announced the Company's participation at the Jefferies 2016 Healthcare Conference to be held in
New York City from June 7-10, 2016.
The aTyr management team will provide an overview of the Company during a presentation at 10:30 a.m. ET on
Friday, June 10, 2016. The presentation will be webcast live through the "Investors" section
of the aTyr Pharma website at www.atyrpharma.com. An audio replay will be available for 30 days following the initial presentation
webcast.
About aTyr Pharma
aTyr Pharma is engaged in the discovery and clinical development of innovative medicines for patients suffering from severe
rare diseases using its knowledge of Physiocrine biology, a newly discovered set of physiological modulators. The Company's lead
candidate, Resolaris™, is a potential first-in-class intravenous protein therapeutic for the treatment of rare myopathies with an
immune component. Resolaris is currently in a Phase 1b/2 clinical trial in adult patients with facioscapulohumeral muscular
dystrophy (FSHD); a Phase 1b/2 trial in adult patients with limb-girdle muscular dystrophy 2B (LGMD2B or dysferlinopathies) or
FSHD; and a Phase 1b/2 trial in patients with an early onset form of FSHD. To protect this pipeline, aTyr built an
intellectual property estate comprising over 70 issued or allowed patents and over 240 pending patent applications that are owned
or exclusively licensed by aTyr, including over 300 potential Physiocrine-based protein compositions. aTyr's key programs are
currently focused on severe, rare diseases characterized by immune dysregulation for which there are currently limited or no
treatment options. For more information, please visit http://www.atyrpharma.com.
Contact:
Mark Johnson
Sr. Director, Investor Relations
mjohnson@atyrpharma.com
858-223-1163
Logo - http://photos.prnewswire.com/prnh/20120809/MM55538LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/atyr-pharma-to-present-at-jefferies-2016-healthcare-conference-300279257.html
SOURCE aTyr Pharma, Inc.